← Latest news 
GLP 1 weight loss drugs may reduce alcohol binges by half in new trial
Health & Fitness
Published on 29 April 2026
Weekly injections cut heavy drinking days dramatically
A new trial suggests GLP-1 weight-loss drugs such as semaglutide could also curb heavy alcohol use. Researchers report weekly injections halved heavy drinking days among adults with alcohol use disorder. Because the same medicine is already used for obesity, the findings could translate into a new treatment pathway for millions, pending further research.
- Trial found semaglutide weekly injections reduced heavy drinking days by half
- Results were seen in adults with alcohol use disorder
- GLP-1 drugs already used for obesity may have a new role
- Researchers are now calling for more studies
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times